SOPHiA GENETICS Management
Management criteria checks 3/4
SOPHiA GENETICS' CEO is Jurgi Camblong, appointed in Mar 2011, has a tenure of 13.08 years. total yearly compensation is $3.33M, comprised of 15.2% salary and 84.8% bonuses, including company stock and options. directly owns 3.77% of the company’s shares, worth $12.45M. The average tenure of the management team and the board of directors is 3.3 years and 3.5 years respectively.
Key information
Jurgi Camblong
Chief executive officer
US$3.3m
Total compensation
| CEO salary percentage | 15.2% |
| CEO tenure | 13.1yrs |
| CEO ownership | 3.8% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 09
Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
Feb 12Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge
Nov 09Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
Sep 21SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
Aug 09We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 18We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$79m |
| Sep 30 2023 | n/a | n/a | -US$69m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$82m |
| Dec 31 2022 | US$3m | US$507k | -US$87m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$93m |
| Mar 31 2022 | n/a | n/a | -US$86m |
| Dec 31 2021 | US$8m | US$394k | -US$74m |
Compensation vs Market: Jurgi's total compensation ($USD3.33M) is above average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Jurgi's compensation has been consistent with company performance over the past year.
CEO
Jurgi Camblong (44 yo)
13.1yrs
Tenure
US$3,332,361
Compensation
Dr. Jurgi Camblong, Ph D., M.B.A., serves as Chief Executive Officer and Director of SOPHiA GENETICS SA since March 2011. Dr. Camblong Co-founded SOPHiA GENETICS SA since March 2011.In 2010, Dr. Camblong...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.1yrs | US$3.33m | 3.77% $ 12.4m | |
| Executive VP | 3.2yrs | no data | 0.094% $ 311.4k | |
| Senior VP & CTO | 2.3yrs | no data | no data | |
| Executive VP & Chief Scientific Officer | 3.3yrs | no data | 0.63% $ 2.1m | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP | 4.8yrs | no data | 0.14% $ 464.6k | |
| Executive VP & Chief People Officer | 5.3yrs | no data | 0.061% $ 201.9k | |
| VP & MD of EMEA | less than a year | no data | no data | |
| Executive VP | 4.2yrs | no data | 0.064% $ 211.2k | |
| Senior VP & Chief BioPharma Officer | 2.3yrs | no data | no data |
3.3yrs
Average Tenure
43yo
Average Age
Experienced Management: SOPH's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.1yrs | US$3.33m | 3.77% $ 12.4m | |
| Independent Non-Executive Director | 3.3yrs | US$257.20k | 0.057% $ 189.3k | |
| Independent Non-Executive Director | 3.8yrs | US$265.94k | 0.11% $ 377.1k | |
| Independent Director | 2.3yrs | US$218.17k | 0.097% $ 320.9k | |
| Independent Non-Executive Director | 9.8yrs | US$233.53k | 0.61% $ 2.0m | |
| Independent Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 3.1yrs | no data | no data | |
| Independent Non-Executive Chairman | 4.8yrs | US$290.93k | 0.28% $ 940.9k |
3.5yrs
Average Tenure
57yo
Average Age
Experienced Board: SOPH's board of directors are considered experienced (3.5 years average tenure).